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Abstract
There remain major gaps in our knowledge regarding the detailed mechanisms by which autoantibodies mediate damage
at the tissue level. We have undertaken novel strategies at the interface of engineering and clinical medicine to integrate
nanoscale visual and structural data using nanorobotic atomic force microscopy with cell functional analyses to reveal
previously unattainable details of autoimmune processes in real-time. Pemphigus vulgaris is a life-threatening autoimmune
blistering skin condition in which there is disruption of desmosomal cell-cell adhesion structures that are associated with
the presence of antibodies directed against specific epithelial proteins including Desmoglein (Dsg) 3. We demonstrate that
pathogenic (blister-forming) anti-Dsg3 antibodies, distinct from non-pathogenic (non-blister forming) anti-Dsg3 antibodies,
alter the structural and functional properties of keratinocytes in two sequential steps - an initial loss of cell adhesion and a
later induction of apoptosis-related signaling pathways, but not full apoptotic cell death. We propose a ‘‘2-Hit’’ model for
autoimmune disruption associated with skin-specific pathogenic autoantibodies. These data provide unprecedented details
of autoimmune processes at the tissue level and offer a novel conceptual framework for understanding the action of self-
reactive antibodies.
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Introduction
Desmosomal junctions are specialized structures critical to
cellular adhesion within epithelial tissues. Disassembly of these
junctions (acantholysis) can occur following autoimmune attack.
Pemphigus vulgaris (PV) is a prototypical organ-specific, poten-
tially life-threatening human autoimmune disease characterized
clinically by flaccid blister formation affecting the skin and mucous
membranes. PV exhibits an intraepidermal split due to acanthol-
ysis of suprabasilar keratinocytes that occurs in the presence of
autoantibodies to specific desmosomal proteins, primarily desmo-
glein (Dsg) 3, and in some cases anti-Dsg1 [1]. Anti-Dsg3
autoantibodies have been shown to induce acantholysis in cultured
keratinocytes [2] and blister formation in vivo in neonatal mice
[3]. Anti-Dsg 1 antibodies are found in approximately 40% of PV
patients, and have also been linked to the development of
Pemphigus foliaceus, a closely related but distinct autoimmune
blistering skin disease, where they are sufficient to induce blister
formation [4].
Although lesion development in patients with PV is generally
associated with high titers of anti-Dsg3 autoantibodies, the precise
molecular mechanisms by which autoantibodies direct the loss of
cell-cell adhesion is not known. In particular, it is unclear if
acantholysis is the direct result of structural changes at the
keratinocyte cell surface that occur subsequent to autoantibody
binding and/or is dependent upon functional changes within the
cell. Three major hypotheses have been proposed regarding the
mechanisms by which anti-Dsg antibody binding to the cell surface
leads to acantholysis in PV: (i) ‘‘steric hindrance’’, the direct
inhibition of Dsg transinteractions [5,6], (ii) depletion of desmo-
somal proteins from the keratinocyte surface [7], and (iii) initiation
of signal transduction events that lead to altered desmosome
assembly, cytoskeleton derangement, cell cycle alterations, and
apoptosis [8]. However, to date, there is no conclusive model of
antibody-mediated acantholysis, and the role of apoptosis is
unsettled. While apoptotic phenomena have been observed in PV,
there is considerable disagreement regarding its role in acanthol-
ysis. Some groups have shown that acantholysis can occur in the
absence of apoptosis [9], and find that hallmarks of apoptosis, such
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as changes in nuclear morphology and cell death, are detectable
only late and subsequent to acantholysis [8]. Others favor the
theory that apoptotic signaling precedes acantholysis, but neces-
sarily leads to apoptosis, and have termed this paradigm
‘‘apoptolysis’’ [10]. Moreover, there is now clear evidence that
PV patients harbor both anti-Dsg3 antibodies that lead to blister
formation (pathogenic) and anti-Dsg3 antibodies that do not lead
to blister formation (nonpathogenic) [2,11]. While both pathogenic
and nonpathogenic autoantibodies are capable of binding to Dsg3
molecules expressed within desmosomal bodies at the keratinocyte
surface, there remains a mystery as to why they lead to different
clinico-pathological outcomes.
To address these outstanding questions, novel experimental
technologies and strategies are required. To date, it has been
extremely challenging to study the morphology of cell junctions by
standard light microscopy in living cells because of their small size
(,1 mm) and complex structure [12]. While immunofluorescence
[13] [14] and electron microscopy [15] have provided insight into
the fine structure of cell adhesion molecules, a model system for
addressing dynamic changes due to (patho-) physiological mech-
anisms has been lacking. Atomic force microscopy (AFM) offers
the advantage of requiring minimal sample preparation, so that
biomolecular structures can be directly studied in situ on viable
samples that recapitulate biological conditions. AFM provides
three-dimensional images of surface topography in unparalleled
resolution allowing for the illumination of structural modifications
of adhesion structures after antibody treatment at a scale that
cannot be revealed by standard light microscopy and also provides
quantitative measures of biological properties (e.g. cellular
elasticity) in a physiologically stable environment.
In this study, we utilized established and novel roboticized AFM
methods to visualize desmosomes in physiologic and disease
conditions at the nanoscale, and to determine detailed nanos-
tructural correlates of the acantholythic process not previously
attainable. Furthermore, we undertook an innovative, interdisci-
plinary approach to link AFM data to functional alterations in cell
behavior to develop a new paradigm for autoantibody mediated
tissue destruction in the skin. We reveal new details regarding the
molecular basis for the functional dichotomy between pathogenic
vs. non-pathogenic autoantibodies. Blister-forming anti-Dsg 3
antibodies produce changes in cellular stiffness that are distinct
from the changes induced by non-pathogenic antibodies. Both
pathogenic and non-pathogenic autoantibodies induce an early,
but incomplete, disruption of intercellular adhesion (‘‘Hit 1’’), but
pathogenic antibodies alone lead to a later induction of apoptosis-
related signaling (‘‘Hit 2’’). These data advance our understanding
of autoimmune destruction and support future nanoscale clinical
applications relevant to the diagnosis and treatment of disease.
Materials and Methods
Keratinocyte cultures and antibodies
For the studies presented here, we used the HaCaT cell line, a
spontaneously transformed human adult skin keratinocyte line that
maintains a near normal phenotype [16]. HaCaT cells recapitu-
late normal human differentiation behavior in vitro, particularly in
terms of desmosomal kinetics [17]. Prior to experimental use,
HaCaT cells were grown to confluence in DMEM medium
(Gibco-Invitrogen, Carlsbad, Ca) supplemented with 10% fetal
calf serum (Gemini Bio-products, West Sacramento, Ca) and 1%
penicillin:streptomycin (10,000 U/ml:10,000 mg/ml; Gibco) at
37uC in a humidified atmosphere containing 5% CO2, and plated
onto poly-L-ornithine (Sigma, St. Louis, MO) coated glass
coverslips placed inside 12-well tissue culture plates.
We used the pathogenic anti-Dsg3 antibody Px4-3 or the non-
pathogenic antibody Px4-4, single-chain variable-region fragment
(ScFv) monoclonal antibodies isolated from a patient with
mucocutaneous PV by phage display. The antibodies were diluted
in phosphate buffered saline (PBS) or cell culture medium at 1:50.
Purified goat anti-mouse Ig antibody (BD Pharmingen, San Jose,
CA) was used as an irrelevant non-binding control antibody, and
mouse anti-human HLA-A, B, C antibody (BD Pharmingen) was
used as a cell-surface binding control antibody, both at a 1:50
dilution. To measure the induction or blocking of apoptotic
processes, in some experiments, Fas Ligand (50 ng/ml), Fas
Ligand neutralizing antibody (0.5 ng/ml), and/or caspase inhib-
itor (20 mM; all BD Pharmingen) was used.
Immunofluorescence Microscopy
HaCaT cells were grown to confluence and fixed in 99.93% dry
methanol for 5 minutes. Monoclonal murine anti-human cytoker-
atin peptide 18 antibody (Sigma, St. Luis, MO) was added at a
1:100 dilution and goat anti-human desmoplakin antibody I/II
(Santa Cruz Biotechnology, Inc, Santa Cruz, CA) was added at a
1:400 dilution and the cells were incubated at 37uC for
30 minutes. After extensive washing with PBS, PE-conjugated
goat anti-mouse IgG1 (Santa Cruz Biotechnology), or AF488-
conjugated donkey anti-goat IgG antibodies were added at 1:400
and 1:200 dilutions for 30 minutes at 37uC to visualize cytokeratin
or desmoplakin stains. After washing with water, polyvinyl alcohol
mounting medium (Dabco, Sigma, St. Luis, MO) was applied. The
immunofluorescence imaging was performed under Nikon Intensi-
light C-HGFI light source with G-2A filter.
SEM imaging
HaCaT cells were fixed in a mixture of 2.5% glutaraldehyde
and 2.5% formaldehyde in 0.1 M sodium cacodylate buffer for 2
hours at room temperature. After rinsing with the buffer only
solution for 15 minutes, the sample went through a sequential
dehydration process with 25%2, 50%2, 75%2, 95%2 and
100% ethanol. The dehydrated sample was then dried inside a
critical point drier (PELCO CPD2, Pelco International Redding,
CA). The image was taken under 20 kv acceleration voltage in a
Joel SEM (JEOL, Peabody, MA) after coating with a thin layer of
gold.
AFM imaging
For imaging living HaCaT cells at low resolution, a Bioscope
AFM (Bruker AXS, Santa Barbara, CA), equipped with a scanner
with a maximum XY scan range of 90 mm690 mm and a Z range
of 5 mm, was used. For imaging living HaCaT cell at high
resolution, a multimode AFM (Bruker AXS) was used. Experi-
ments were performed in culture medium at room temperature
using silicon nitride cantilevers with a spring constant of 0.38 N/m
and mounted in a commercially available fluid cell module. All
scans were completed by taking 2566256 point scans and
recording topographic data. Both the trace and retrace images
were measured and compared. For fixed cell imaging under
antibody treatment, different types of antibody (pathogenic anti-
Dsg3 antibody, non-pathogenic anti-Dsg3 antibody, non-binding
irrelevant antibody and binding irrelevant antibody) were added to
individual wells in DMEM medium for 24 h at a final antibody
concentration of 10 mg/ml. Cell fixation was achieved by
incubation in 3.7% formaldehyde (Sigma-Aldrich) for at least
15 minutes and visualized using the multimode AFM. For live cell
imaging under antibody treatment, the antibodies were added
without fixation at a final concentration of 10 mg/ml under
continuous Bioscope AFM observation.
Nanorobotic Investigation of Autoimmune Pathology
PLOS ONE | www.plosone.org 2 September 2014 | Volume 9 | Issue 9 | e106895
Cell elasticity measurements
Force-displacement curves measurements were performed
under a Nanoscope IV Bioscope (Bruker AXS). Silicon nitride
tips with a spring constant of 0.06 N/m and a tip radius around
10 nm were used to probe the cells. An indentation speed of
1.8 mm (corresponding to a frequency of 0.3 Hz) was selected to
reduce the cell viscous effect [18] but maintain a sufficient time
frame to capture dynamic changes of cell properties. To ensure
data reliability, all measurements were performed in the cell
center. During this process, the indentation force was controlled at
10 nN and the indentation depth 500 nm. Collected force-
displacement curves were processed with Matlab routines to
convert them to force-indentation curves and then fitted with the
Hertz model to generate the Young’s modulus (E). The tip half
opening angle is 17.5 degrees and the Poisson ratio is set as 0.5.
Nanorobotic surgery
AFM-based nanorobotics enables accurate and convenient
sample manipulation and drug delivery. This capability was used
in the current study to control the AFM tip position over the
intercellular junction area, and apply vertical indentation forces, so
that bundles of intercellular adhesion structures can be dissected
precisely with an accuracy of less than 100 nm in height. We used
a tip sharp enough (2 nm in tip apex diameter) to penetrate the
cell membrane and the intermediate filaments. It has been shown
that intermediate filaments have extremely high tensile strength by
in vitro AFM stretching [19]. Thus, the vertical force and moving
speed of the AFM cantilever (0.06 N/m in vertical spring constant)
was controlled at a vertical force of 5 nN at an indentation speed of
0.1 mm/s to guarantee the rupture of the filament and to partially
dissect cell adhesion structures between two neighboring cells.
Measurement of apoptosis and cell death by flow
cytometry
HaCaT cell were grown to confluency as describe above. Two
days after reaching confluency (to insure formation of strong
intercellular adhesion structures), cells were treated with the
respective anti-Dsg3 or irrelevant control antibodies for the
indicated time periods before harvesting the cells by trypsinization.
In some experiments, Fas Ligand (BD Pharmingen) was added
48 h before harvesting the cells. In experiments including Fas
Ligand neutralizing antibody (BD Pharmingen) or caspase
inhibitor (BD Pharmingen), these agents were added 30 min prior
to adding Fas Ligand or the anti-Dsg3 antibody. Trypsinized cells
were washed in PBS and combined with dead cells from their
conditioned supernatants. To detect apoptotic and/or dead cells,
HaCaT cells were re-suspended in staining buffer, and annexin V
antibody and/or propidium iodide were added as per manufac-
turer’s instructions (Annexin V-FITC apoptosis detection kit, BD
Pharmingen). Apoptosis and cell death was analyzed by FACS on
a Vantage SE (BD Biosciences) flow cytometer.
Results
Nanoscale visualization of keratinocyte junctions under
physiologic and disease conditions
To validate the applicability of AFM for the investigation of cell-
cell adhesion, we conducted high magnification AFM imaging of
fixed HaCaT cells, a well-established keratinocyte cell line. We
show that the AFM images correspond well with SEM imaging
(considered the gold standard in high resolution imaging of
detailed intercellular adhesion structures in previous work [20])
(Fig. 1A).
Next, we demonstrate a close correlation of AFM images with
IF images that visualize cytokeratin, an intermediate filament
protein, and desmoplakin, an anchoring protein that links
desmosomal proteins to intermediate filaments (Fig. 1B). Auto-
antibody-treated cells (Fig. 1C) display a distinctive enlarged
spacing between neighboring cells when compared to untreated
cells (Fig. 1B), indicating cell dissociation that is clearly observed
both by IF and AFM in fixed cells. In the higher resolution AFM
images of untreated fixed keratinocytes (Fig. 2A), we observe
structures in parallel organization between the cell membranes.
However, in cells incubated with pathogenic anti-Dsg3 antibody
or non-pathogenic anti-Dsg3 antibody for 24 h, these structures
linking adjacent cells are no longer clearly detectable (Fig. 2A
and B, respectively), indicating that Dsg3-specific antibody
binding leads to a perturbation of normal cell-cell adhesion.
Conversely, the addition of two disease-irrelevant antibodies (goat
anti-mouse Ig and mouse anti-human HLA A, B, C) does not alter
the intercellular structures observed without treatment (Fig-
ure 2C and D, respectively).
To visually follow disease processes in real-time, we obtained
images of living keratinocytes in culture before and after treatment
with the same test and control antibodies used above over a time-
course of 30 min to 4 h. Prior to antibody treatment (0 h),
multiple intact intercellular structures can be observed. After
treatment with the blister-inducing pathogenic anti-Dsg3 anti-
body, an initial perturbation of cell-cell adhesion can be visualized
between 30 m–1 h, with all cells completely disconnected after 2 h
(Fig. 2A). Treatment with the non-pathogenic antibody, which
does not lead to blister formation in vivo, results in a similar initial
disruption of cell-cell adhesion structures as seen with the
pathogenic antibody. However, the non-pathogenic antibody
associated changes appear with a delayed onset and do not lead
to a complete loss of cellular shape (Fig. 2B). Neither of the
irrelevant control antibodies alters the intercellular structures
between adjacent cells at the corresponding time points (Fig. 2C
and D). These data demonstrate the facility of AFM technology
not only to document autoantibody associated effects at static time
points in fixed specimens, but also to track autoantibody mediated
effects on intracellular adhesion in real-time.
Nanorobotic methods define cell structural correlates of
autoantibody binding
Dynamic mechanical properties of cells are increasingly being
recognized as indicators and regulators of physiological processes
[21]. For example, it has been shown that changes in cell
elasticity/stiffness can effectively and reliably differentiate cellular
conditions, such as non-cancerous vs. metastatic cells [18,22], or
the induction of apoptosis [21]. To obtain dynamic measurements
under physiological and pathophysiological conditions, we con-
tinuously measured elasticity/stiffness changes over a 4-hour time
course following antibody treatment of HaCaT cells. In untreated
cells, or those treated with irrelevant control antibodies, the overall
elasticity remained at the same level over the measurement
interval of 4 hours with means ranging from 32 kPa to 36 kPa
(Fig. 3A, D, and E, respectively). In the presence of the non-
pathogenic antibody Px4-4, however, elasticity initially decreases
within 1 h from baseline levels of 32.565.1 kPa to 17.662.6 kPa,
then returns to baseline after 2 h, and remains between 35 kPa
and 40 kPa thereafter, at similar levels to the initial value before
antibody (Fig. 3C). In cells treated with the pathogenic antibody
Px4-3, stiffness first drops at 1 hour to 18.664.6 kPa, similar to the
results with non-pathogenic antibody. However, in contrast to the
non-pathogenic antibody condition, at 2 h there is a consistent,
Nanorobotic Investigation of Autoimmune Pathology
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sharp increase (,three-fold) in stiffness to levels around 70 kPa for
the remaining period (Fig. 3B).
To define the (patho-) physiological correlates of the early
decrease in cell stiffness induced by both pathogenic and non-
pathogenic antibody binding, we first investigated the extent to
which the directed detachment of intercellular adhesion molecules
via the manipulation of calcium levels in culture media (calcium
depletion) or by nanorobotic surgical methods (nanodissection)
affects elasticity measurements.
Desmosomal adhesion in vitro is calcium dependent. When the
calcium concentration is raised, desmosomes form rapidly between
cells cultured. However, the formation of cultured desmosomes
can be interrupted by the depletion of calcium from the growth
medium (below ,0.1 mM) [23] due to the formation of half
desmosomes that are subsequently internalized [24]. Calcium-
depleted cells grow separately from their neighboring cells, or, if
they had previously reached confluence, dissociate from adjacent
cells.
We show that cells grown in calcium-containing medium form
stable cell attachments to their neighboring cells, exhibit a
somewhat ‘‘flat’’ appearance (diameter ,25 mm, height ,1 mm),
and intercellular filaments bridging neighboring cells are clearly
observed (Fig. 4A1, -B1, -C1). Calcium depletion leads to a loss
of cell-cell adhesion that can be observed microscopically as an
enlarged spacing between cells, and via AFM by a disappearance
of intercellular filaments (Fig. 4A2 and B2). Additionally, calcium
depleted cells become approximately three times smaller in
diameter (,10 mm), but almost three times higher (,3 mm)
(Fig. 4C2). Once Ca2+ containing medium is reconstituted to
cultures, cells recover to normal pre-depletion shape (Fig. 4A3, -
B3, -C3). AFM-measurements of cellular stiffness at the 3 states
(pre-depletion, post-depletion, and recovery) clearly show that the
loss of intercellular adhesion, and thus change in cell shape, is
tightly correlated with a decrease in cellular stiffness (from
36.564.7 kPa to 19.163.9 kPa). The re-formation of intercellular
adhesion, however, restores stiffness back to levels seen before the
loss of cell-cell connections (35.266.7 kPa) (Fig. 4D).
As an alternative method of disrupting intercellular adhesion,
we performed novel, targeted nanodissection at the intracellular
adhesion junction of keratinocytes using an AFM based nanor-
Figure 1. Integrated scanning electron microscopy (SEM), immunofluorescence (IF) and AFM imaging of intercellular adhesion
structures. A: Correlation of SEM imaging with AFM imaging. Identically cultured plates of confluent HaCaT cells were fixed and imaged by SEM and
Multimode AFM in increasing magnifications. The lower magnification images (SEM: A1, A2; AFM: A5, A6) show the cells with clear boundaries
between neighboring cells where cell-cell adhesion occurs. The higher magnification images (SEM: A3, A4; AFM: A7, A8) show details of the
adhesion junction with strand-shaped structures in parallel distribution between two cells. B: Correlation of IF imaging with AFM imaging. The same
area on a confluent slide of HaCaT cells was captured simultaneously by IF and AFM after fixation of the cells. For IF imaging, HaCaT cells were labeled
with anti-cytokeratin antibodies (red) and anti-desmoplakin antibodies (green). AFM images were captured by Bioscope AFM at increasing resolution
with scan sizes of 100 mm (B2), 50 mm (B3) and 20 mm (B4). C: Correlation of IF imaging (C1) with AFM imaging [scan sizes of 100 mm (C2), 50 mm
(C3) and 20 mm (C4)] after treatment with 10 mg/ml of the pathogenic anti-Dsg3 antibody Px4-3 for 24 h.
doi:10.1371/journal.pone.0106895.g001
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obotic surgery system. The AFM topography image (Fig. 4E)
shows three keratinocytes connected by intercellular strands. Prior
to nanodissection, the height of the cell junction was recorded.
After nanodissection, a loss of intercellular strands is observed in
the AFM images (see Fig. 4E2, black arrow), and is associated
with a reduction in junction height by less than 100 nm. This
process was also associated with a decrease in diameter and
increase in cellular height of cells adjacent to the nanodissected
area similar to the changes in cell shape observed by Ca+-
depletion above (data not shown). Corresponding AFM measure-
ments of cellular elasticity indicate that the stiffness of an
individual HaCaT cell decreases from 30.061.5 kPa before to
20.562.8 kPa after nanodissection (Fig. 4F).
Functional correlates of nanostructural alteration
associated with autoantibody binding
To define the (patho-) physiological correlates of the increase in
cell stiffness induced by pathogenic-, but not non-pathogenic
antibody binding after the initial decrease in cell stiffness described
above, we next investigated whether the internal remodeling of the
cytoskeleton in cells undergoing apoptosis is reflected in dynamic
changes in cell structural properties measurable by AFM, as has
been suggested [21]. While the morphological characteristics
typically associated with apoptosis are not necessarily detected in
the histopathology of PV lesions, increased expression of apoptotic
signaling molecules has been found in both PV lesions and patient
serum when compared to healthy controls, and PVIg can trigger
the activation of apoptotic signaling pathways in vitro [8]. Thus,
we investigated whether the late increase in cell stiffness detectable
at 2 h after pathogenic antibody treatment has its pathophysio-
logical correlate in an induction of apoptotic processes by
examining the extent to which (i) apoptosis is induced by
pathogenic anti-Dsg3 antibodies, (ii) similar levels of cell stiffness
increases can be observed with established inducers of apoptosis,
and (iii) the antibody induced stiffness increase can be reversed by
blocking apoptotic signaling.
We first measured whether pathogenic anti-Dsg3 antibodies
induce an activation of apoptotic pathways in cultured keratino-
cytes. In cells treated with pathogenic anti-Dsg3 antibodies, we
observe an increase in combined Annexin V and PI positivity
starting at 4 h, with a peak at 12 h and a return to baseline levels
at 24 h (Fig. 5A). The non-pathogenic antibody induces a slight
increase in Annexin V and PI positivity as well, but this increase
does not reach significant levels at any time point, peaks later
(around 16 h) and returns to baseline levels earlier (at 20 h)
(Fig. 5A).
To verify that the sustained increase in cellular stiffness observed
after pathogenic anti-Dsg3 antibody binding can also be found as a
result of apoptosis induction, we used the well-established
apoptosis-inducer Fas ligand (FasL). Addition of FasL significantly
increases the number of apoptotic HaCaT cells in culture, while
pretreatment of FasL-treated cultures with FasL neutralizing
antibody significantly reduces FasL-induced apoptosis back to
baseline levels (Fig. 5B). Parallel AFM force measurements show
that untreated HaCaT cells and Fas ligand treated cells have a low
peak in their stiffness distribution around 30 kPa and a high peak
Figure 2. AFM imaging of autoantibody mediated desmosomal disruption in fixed and living cells. In a first set of experiments, HaCaT
cells were grown to confluence, and left with no antibody treatment, or were treated for 24 h with (A) the pathogenic anti-Dsg3 antibody Px4-3, (B)
non-pathogenic antibody Px4-4, (C) non-binding irrelevant control antibody goat anti-mouse Ig, or (D) irrelevant control antibody mouse anti-human
HLA A, B, C (all antibodies at 10 mg/ml). Images were captured in high resolution (range 6–8 mm) by Multimode AFM after fixation of the cells. In a
second set of experiments, confluent HaCaT cells were imaged live before antibody treatment or treated with the antibodies listed above (A–D) for
30 min, 1 h, 2 h, 3 h, and 4 h.
doi:10.1371/journal.pone.0106895.g002
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around 80 kPa. In FasL treated cells the high stiffness peak sharply
increases (28% of all cells, Fig. 5C2) when compared to untreated
cells (12%, Fig. 5C1). When apoptosis is blocked by FasL
neutralizing antibody, the second peak of higher stiffness
completely disappears (Fig. 5C3). These gain of function and
loss of function data indicate that the induction of apoptosis in
HaCaT cell cultures leads to a sharp increase in cell stiffness.
However, our observation of the complete disappearance of cells
displaying high stiffness in the presence of FasL inhibitor while low
levels of background apoptosis remain detectable by FACS
suggests that some FasL-independent apoptosis may have been
induced before addition of FasL inhibitor. This baseline apoptosis
can still be detected by FACS after 44 h of culture, while AFM
detects the complete blockage of FasL-dependent apoptotic
signaling mechanisms in this experimental set-up.
To investigate the extent to which the secondary increase in
cellular stiffness produced by pathogenic autoantibodies can be
linked to the induction of apoptosis, we blocked apoptosis in
pathogenic anti-Dsg3 antibody treated cells by (a) inhibiting all
caspases, a family of cysteine proteases that play essential roles in
programmed cell death, or by (b) blocking the Fas/FasL pathway.
Compared to baseline (Fig. 6A), addition of Px4-3 pathogenic
antibody leads to a sharp increase in the number of cells with
higher stiffness (22.5%, Fig. 6B) that is similar to the distribution
of cell stiffness (both in terms of percentage of cells showing cellular
stiffening as well as Young’s modulus values) as treatment with
FasL (see Fig. 5C2). Pre-treatment of HaCaT cells with caspase
inhibitor prior to the addition of Px4-3 antibody completely
abrogates the development of cells with a stiffer profile, even below
background levels (Fig. 6C), indicating that anti-Dsg3 antibody-
induced apoptotic processes and blocking thereof can be
monitored by AFM stiffness measurements. Pre-treatment of
HaCaT cells with FasL neutralizing antibody before addition of
Px4-3 antibody, however, does not reduce the number of stiffer
cells (Fig. 6D). The disparate findings regarding the blocking of
caspases or the FasL pathway indicate that while inhibition of
apoptotic processes can reverse pathogenic autoantibody mediated
phenomena, they are not mediated by the Fas/FasL signaling
pathway. Independent of the stiffness induced by the pathogenic
anti-Dsg3 antibodies, a small amount of cultured epithelial cells
spontaneously display a stiffer profile that is amenable to blockage
by both FasL- as well as caspase inhibition.
2-Hit hypothesis of anti-Dsg3 autoantibody mediated
pathology in PV
Based on the AFM imaging and mechanical data as well as the
functional experiments presented above, we propose a novel ‘‘2-
Hit hypothesis’’ of anti-Dsg3 autoantibody effects in PV
(Fig. 7). ‘‘Hit 1’’ reflects structural changes in the keratinocyte
that are induced both by pathogenic (blister-forming) and non-
pathogenic (non blister-forming) antibodies. ‘‘Hit 2’’ involves a
functional change in the keratinocyte biology that is promoted by
pathogenic, but not non-pathogenic antibodies. In this model,
‘‘Hit 1’’ has the pathophysiological correlate of an initial, but
Figure 3. AFM-guided elasticity measurements on HaCaT cells before and after treatment with anti-Dsg3 and control antibodies.
HaCaT cells were grown to confluence and elasticity was measured in the center of individual cells with an indentation speed of 1.8 mm/s
(corresponding to a frequency of 0.3 Hz) over a 4 h time interval (A). At each time point, between 20 and 40 HaCaT cells were tested, and the force
curves obtained from these measurements were processed to generate the corresponding Young’s modulus as a measure of cellular elasticity. In
parallel experiments, measurement were obtained before antibody treatment and after treatment with 10 mg/ml of the pathogenic anti-Dsg3
antibody Px4-3 (B), the non-pathogenic antibody Px4-4 (C), the non-binding irrelevant control antibody goat anti-mouse Ig (D), or the binding
irrelevant control antibody mouse anti-human HLA A, B, C (E). Each bar represents the average and standard deviation of repeated measurements
obtained over a 1 h period. Each graph represents the average of a minimum of 3 separate experiments for each antibody. The differences in cellular
elasticity between conditions within 1 h after antibody treatment compared pre-antibody treatment, and 1–2 h, 2–3 h, and 3–4 h after antibody
treatment, and were assessed by Student’s t-test and are depicted as * = p#0.05.
doi:10.1371/journal.pone.0106895.g003
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Figure 4. Decreased cell stiffness after dissociation of intercellular adhesion. HaCaT cells were cultured in calcium-containing medium for 4
days until reaching confluence (A1, B1, C1), and then calcium-depleted for 2 days (A2, B2, C2), or calcium-depleted for 2 days and then
reconstituted in calcium-containing medium for another 2 days (A3, B3, C3). At each interval, we obtained (A) microscopic images (original
magnification: 100x), (B) AFM topography images (scan size B1, 50 mm; B2, 20 mm; B3, 33.3 mm), and (C) height measurements at the cross section
of an individual cell. In parallel, AFM-guided cell stiffness measurements were obtained by AFM nanomechanical measurement of 50 different cells
under each of the conditions described above (D); Each bar represents the average and standard error of the mean (SEM) of repeated measurements
for each condition. In a second set of experiments, cell adhesion structures in confluent HaCaT cell cultures grown under standard conditions were
visualized by AFM prior to (E1) and after (E2) dissection of cell adhesion structures by nanorobot-guided surgery (traveling distance of AFM tip
,8 mm; scan size: 19.2 mm; upper panel). The corresponding cross section height measurements show a height decrease by slightly less than 100 nm
(from ,10 nm to 2100 nm in the encircled area; lower panel); the arrow in the AFM images points to an intact intercellular connection before
cutting (E1) and the disappearance thereof after cutting (E2). F. Cell stiffness was measured before and after the nanorobotic surgery and decreases
from 30.061.5 kPa to 20.562.8 kPa, respectively. The bars represent the mean and standard error of the mean (SEM). E and F. The differences in
cellular elasticity between conditions before and after Ca+-depletion and recovery and before and after nano-dissection were assessed by Student’s t-
test and are depicted as * =p#0.05.
doi:10.1371/journal.pone.0106895.g004
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incomplete cellular dissociation, while ‘‘Hit 2’’ correlates with the
initiation of apoptosis-related signaling pathways.
Discussion
While AFM has been previously used to study the binding
properties of anti-Dsg1 and 3 antibodies to planar surfaces in a
cell-free environment [6,25], we have applied novel nanorobotic
AFM technologies for the investigation of autoimmune pathome-
chanisms in vitro. We show that, in addition to visually tracking
the effects of PV-associated anti-Dsg3 autoantibody binding on
cellular adhesion in high resolution and real-time, AFM can
reliably detect nanostuctural changes at the intact cell surface in
response to pathogenic (blister forming) and non-pathogenic (non
blister forming) antibody binding and downstream signaling events
that allow conclusions regarding disease pathomechanisms rele-
vant to autoimmunity. Specifically, our experiments indicate that
an early decrease in cellular stiffness detected by AFM after
binding of both pathogenic as well as nonpathogenic anti-Dsg3
antibodies is consistent with a disruption of cellular adhesion,
Figure 5. A. Induction of apoptotic processes by pathogenic anti-Dsg3 antibodies. Confluent HaCaT cell cultures were treated with 10 mg/
ml of either the pathogenic anti-Dsg3 antibody Px4-3 or the non-pathogenic anti-Dsg3 antibody Px4-4 for 4, 8, 12, 16, 20 and 24 h. Induction of
apoptosis was assessed by measuring the expression of both Annexin V and PI positivity by FACS. Each experiment was performed in triplicate.
Values are presented as percent induction when compared to baseline apoptosis levels in untreated cells harvested in parallel. The levels of annexin V
and/or PI positivity induced by pathogenic anti-Dsg3 antibodies are significantly elevated at 12, 16 and 20 h when compared to untreated cells (p#
0.05, Student’s t-test). B and C. Fas ligand-induced apoptosis correlates with a marked increase in keratinocyte stiffness. Subconfluent
HaCaT cell cultures were left untreated (B1), treated with 50 ng/ml FasL (B2) or pretreated with FasL neutralizing antibody (0.5 mg/ml) for 30 min
before addition of 50 ng/ml FasL (B3). In untreated HaCaT cells, 4.5260.32% of all cells are Annexin V- and PI positive as measured by flow cytometry
after 44 h of culture. Addition of FasL significantly increases the number of apoptotic cells to 14.6360.11% (p,0.01, FasL vs. untreated). Pretreatment
of FasL-treated cultures with FasL neutralizing antibody significantly reduces FasL-induced apoptosis back to baseline levels 5.9561.28% (p,0.01,
FasL + FasL inhibitor vs. FasL alone). In parallel experiments, 100 cells were randomly selected to collect AFM force-displacement curves to generate a
Young’s modulus value for each cell. The combined Young’s modulus values for each condition were plotted as Gaussian distribution curves. (C1)
Normal cell stiffness distribution in untreated cells (Gaussian fit with peaks around 31.2 kPa and 77.8 kPa). (C2) Cell stiffness distribution in Fas ligand-
treated cells (Gaussian fit with peaks around 31.5 kPa and 81.7 kPa). (C3) Cell stiffness distribution in Fas ligand treated cells pretreated with Fas
ligand neutralizer (Gaussian fit with single peak around 29.1 kPa). Data are representative of three independent experiments performed in duplicate.
doi:10.1371/journal.pone.0106895.g005
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while a later increase in cellular stiffness induced by pathogenic,
but not non-pathogenic antibodies may be the correlate of
initiation of apoptosis-related signaling.
Both the calcium depletion as well as the nanorobotic
manipulation experiments indicate that a disruption of intercellu-
lar adhesion leads to a dependable decrease in cellular stiffness,
and are consistent with the initial decrease in cell stiffness
measured by AFM within one hour after addition of autoantibody.
Our data fits well with reports in the literature that see early effects
of PV IgG on cell adhesion [26,27] and cytoskeleton disassembly
[28] within 30 min to 2 h. While significant Pemphigus IgG
induced acantholysis usually takes 12–24 h to occur (reviewed in
[26]), complete loss of cell adhesion has been observed within 1–
6 h after antibody treatment with pathogenic antibody in
experimental models [29].
Our in vitro apoptosis and caspase inhibition experiments
indicate that an initiation of apoptosis-related signaling leads to a
consistent increase in cell stiffness, and are consistent with the
secondary, longer lasting increase in cell stiffness that is induced by
pathogenic, but not non-pathogenic anti-Dsg3 antibodies begin-
ning at 1–2 h after addition of antibody. We show that pathogenic
antibodies induce a significant externalization of phosphatidylser-
ine (PS) (as measured by Annexin V binding in this study), a
common and accepted method for detecting apoptosis [30].
However, the return to baseline levels within 24 h after pathogenic
antibody treatment indicates that the cells, while exhibiting
apoptosis-related phenomena, have not undergone terminal
apoptosis. Our data support previous findings by Pelacho et al.
[31] that showed nuclear changes characteristic of apoptosis, with
a clear peak after an 8 h incubation with PV-IgG, but a decrease
thereafter. Contrary to long held beliefs regarding the irreversible
fate of apoptotic cells, it has recently been shown that the initiation
of apoptosis can be reversible with only transient exhibition of
morphological signs of apoptosis at the cellular level [32].
Additionally, phosphatidylserine (PS) externalization (as measured
by Annexin V binding in this study) is not restricted to apoptotic
cells but has also been described for human CD8 cytotoxic T
lymphocytes that reversibly expose PS upon T-cell receptor
mediated antigen recognition [33]. Thus, similar to the reversible
PS exposure on T cells upon antigen recognition, the reversible PS
externalization on keratinocytes seen in our study upon autoan-
tibody binding may indicate an initiation of apoptosis-related
signaling cascades that has the potential to, but does not
necessarily progress to apoptotic cell death in all conditions.
Figure 6. Blocking of pathogenic anti-Dsg3 antibody-induced increase in keratinocyte stiffness by caspase inhibition, but not Fas
ligand neutralization. HaCaT keratinocytes were grown to confluence and cell stiffness was measured by AFM (expressed as percent of cells
measured at a given Young’s Modulus). Cell stiffness distribution in (A) untreated cells (Gaussian fit with peaks around 32.0 kPa and 75.2 kPa), (B) cells
treated with the pathogenic anti-Dsg3 antibody Px4-3 (10 mg/ml) alone for 8 h (peaks around 34.8 kPa and 83.5 kPa), (C) cells pretreated with caspase
inhibitor (20 mM) 30 min before addition of pathogenic antibody (single peak around 17.7 kPa), (D) cells pretreated with Fas ligand neutralizing
antibody (0.5 mg/ml) 30 min before addition of pathogenic antibody (peaks around 29.1 kPa and 73.0 kPa), (E) treated with caspase inhibitor (20 mM)
alone for 8.5 h (single peak 30.1 kPa), or (F) treated with Fas ligand neutralizing antibody (0.5 mg/ml) alone for 8.5 h (single peak 32.3 kPa. The single
peak of cells of low stiffness observed for treatment with caspase inhibitor (E) and FasL neutralizing antibody (F) alone indicates that the
spontaneous apoptosis seen in untreated cells can be completely abrogated by these two blockers.
doi:10.1371/journal.pone.0106895.g006
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An activation of caspases has been observed in PV model
systems, and caspase inhibitors have been shown to block PV IgG-
induced acantholysis in keratinocyte monolayers and skin organ
culture [34,35]. Our finding that a caspase inhibitor can
completely abrogate anti-Dsg3 induced changes in cell stiffness
supports the notion that apoptosis-related signaling mechanisms
are indeed involved in the downstream processes after antibody
binding. However, as stated earlier, apoptosis-related signaling in
PV may not necessarily progress to cell death, but exert its
influence elsewhere, such as by targeting proteins involved in the
regulation of cell contacts and of the cytoskeleton during apoptosis
[36]. As such, caspase 3 has been shown to specifically cleave the
cytoplasmic tail of Dsg3 and help release its extracellular domain
from the cell surface, resulting in the disruption of the desmosome
structure and contributing to cell rounding and disintegration of
the intermediate filament system [35]. Along these lines, our
ability to block anti-Dsg3 induced cell stiffening by blocking
caspases could simply reflect an inhibition of Dsg3 cleavage, and
not apoptosis. However, in keeping with our own data on the
disruption of i.c. adhesion structures presented above, a disinte-
gration of the keratin network would be expected to lead to cell
softening rather than stiffening. Thus, it is conceivable that the
anti-Dsg3 induced cell stiffening observed by AFM in this study
can be viewed as a sensitive marker for the early initiation of
apoptosis-related signaling pathways that may contribute to
cellular dissociation, but not necessarily reach full apoptotic cell
death. It is important to note that auto-antibody induced changes
in cell topography and elasticity were detected by AFM at much
earlier time points (starting at 30 min) than changes measured by
standard flow cytometry assays (starting at 4 h), which suggests
that AFM is a much more sensitive technique that allows for the
detection of structural changes that precede downstream changes
in cellular biology. Future studies into early signs of cell
dissociation (such as retraction of keratin filaments) and the
induction of early apoptotic and non-apoptotic signaling processes
(caspase activation, p38 MAPK phosphorylation) will have to be
correlated with the changes in cellular elasticity we observed in this
paper in order to prove a direct causal relationship between these
phenomena.
The inability of FasL neutralizing antibodies to reverse the
pathogenic antibody-induced increase in stiffness is somewhat
surprising, as an activation of the Fas-FasL apoptotic pathway has
repeatedly been implicated in PV pathomechanisms [37,38].
However, previous studies relied on observations from biopsy
materials or in vitro studies with patient sera or purified IgG. It
has been shown that sera from untreated PV patients contains
high levels of FasL [37], which could conceivably lead to apoptosis
independent of the effect of anti-Dsg antibodies. This notion is
supported by the fact that inhibition of FasL or caspase 8 can only
partially inhibit PV sera induced apoptosis [37]. In addition to
containing FasL, serum autoantibody profiles vary among patients
and may contain autoantibodies to targets other than Dsg [39],
whose effects have not been well studied. In this study, we used a
well-characterized and reproducible source of pathogenic PV anti-
Dsg mAbs [11,29] with non-pathogenic PV anti-Dsg mAbs as
controls, in order to discern effects that can be attributed solely to
the action of anti-Dsg3 on its cellular target.
The data presented in this study support the notion that a
dissociation of cell adhesion structures precedes the detection of
apoptosis-related signaling phenomena after pathogenic antibody
Figure 7. Two-Hit hypothesis for antibody-mediated damage in the skin. Pathogenic and non-pathogenic antibodies have distinct effects
on keratinocyte biology: ‘‘Hit 1’’ reflects structural changes in the keratinocyte that are induced both by pathogenic and non-pathogenic antibodies
within 1 hour with the pathophysiological correlate of an initial, but incomplete cellular dissociation. ‘‘Hit 2’’ involves a functional change in
keratinocyte biology that is promoted by pathogenic, but not non-pathogenic antibodies within 1–4 h with the pathophysiological correlate of an
initiation of apoptosis-related signaling pathways. Since the non-pathogenic antibody leads to an initial cellular dissociation that is also seen with
pathogenic antibody binding, but does not alter the overall shape of the cell and does not induce the later cell structural changes seen with
pathogenic antibodies, it follows logically that ‘‘Hit 2’’ is needed to progress to clinical disease, while ‘‘Hit 1’’ may be a reversible phenomenon.
doi:10.1371/journal.pone.0106895.g007
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attack. Based on the AFM imaging and mechanical data as well as
the functional experiments presented here, we propose a novel ‘‘2-
Hit hypothesis’’ of anti-Dsg3 autoantibody effects in PV
(Fig. 7). Our hypothesis offers a new paradigm to explain why
certain circulating autoantibodies lead to clinically overt blister
formation on mucosal and cutaneous surfaces (i.e. pathogenic
antibodies), while others do not result in blisters despite targeting
the same autoantigen (i.e. non-pathogenic antibodies). It appears
that simply interfering with desmosomal adhesion (either by steric
hindrance or inducing depletion of desmosomal proteins from the
cell surface as hypothesized before) is not sufficient to induce PV
pathology, but that there is a requirement for this initial step to be
followed by a secondary signaling event that ultimately induces
acantholysis. This secondary signaling event appears to incorpo-
rate apoptosis-related phenomena, but does not require terminal
cell death. This secondary signaling event could conceivably
include p38 MAPK signaling, which has been suggested to be
downstream of the loss of intercellular adhesion in PV [40].
Interestingly, a biphasic activation of p38 MAPK has been
observed in response to Pemphigus foliaceous (PF) IgG, and the
later peak has been suggested to lead to the activation of apoptotic
pathways, but only lead to overt apoptosis in a small number of
cells [41]. It remains to be determined whether the cell structural
phenomena detected by AFM after pathogenic antibody binding
are linked to MAPK activation and other intracellular events.
Future studies are also needed to determine whether the
dichotomy in autoantibody effects is related to the relative
‘‘strength’’ of the autoantibody (it is theoretically possible that
the presumed ‘‘non’’-pathogenic antibody does hold pathogenic
potential at much higher concentrations per target cell not tested
here), or to binding of different epitopes within the extracellular
domains of the target molecule (such as in the amino-terminal
region of Dsg [42]) which may be influenced by the 3D nature of
intact tissue.
We demonstrate that AFM is an exquisitely sensitive method to
detect cellular mechano-structural changes at a higher resolution
and at earlier time-points than standard techniques. Advances in
this technology allowed us to assign the sequence of specific
nanostructural and functional changes consequent to the binding
of pathogenic vs. non-pathogenic antibodies, and define critical
pathways and processes responsible for autoimmune pathology.
This information may facilitate predictive, nanoscale screening of
individuals harboring disease relevant autoantibodies. The ability
to distinguish the subset of autoantibody specificities within
individuals that are disease causing (pathogenic) vs. those that
are not could identify patients at risk for autoimmune progression
and prioritize the key autoantibodies/antibody producing cells for
therapeutic targeting in a given patient. We further envision the
development of nanoscale devices designed to validate the in situ
effectiveness of existing and emerging therapies. AFM-guided
detection of mechanostructural changes in cells targeted by
autoimmune processes has the potential to be applied to other
models of autoimmunity in order to functionally investigate
biological pathways and blockage of those pathways with potential
novel and personalized therapeutic agents.
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